Back
NVIDIA Corp. Vs. Madrigal Pharmaceuticals, Inc. Sector Stock Comparison
Sell
47
NVDA
NVIDIA Corp.
Last Price:
$175.03
Seasonality Move:
15.29%
Buy
64
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$571.29
Seasonality Move:
13.5%
Sell
47
NVIDIA Corp. (NVDA)
is a Sell
Is NVIDIA Corp. a Buy, Sell or Hold?
-
The current NVIDIA Corp. [NVDA] share price is $175.02. The Score for NVDA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
NVDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Buy
Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $571.44. The Score for MDGL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVDA Stock Price Chart
What is NVIDIA Corp.'s stock price today?
-
The NVIDIA Corp. share price today is $175.02Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVDA is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals, Inc.'s stock price today?
-
The Madrigal Pharmaceuticals, Inc. share price today is $571.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing slight buying pressure.
NVDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.94 | Sell |
| Relative Strength Index (14 RSI): | 39.86 | Sell |
| Chaikin Money Flow: | -184345658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (178.44 - 189.54) | Sell |
| Bollinger Bands (100): | (174.49 - 190.17) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 20 | Buy |
| Relative Strength Index (14 RSI): | 59.62 | Buy |
| Chaikin Money Flow: | 50743 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (528.97 - 586.99) | Buy |
| Bollinger Bands (100): | (367.46 - 524.18) | Buy |
NVDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 181.95 | Sell |
| 20-day SMA: | 181.94 | Sell |
| 50-day SMA: | 186.85 | Sell |
| 200-day SMA: | 156.07 | Buy |
| 8-day EMA: | 180.97 | Sell |
| 20-day EMA: | 182.89 | Sell |
| 50-day EMA: | 183.79 | Sell |
| 200-day EMA: | 163.81 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 570.14 | Buy |
| 20-day SMA: | 568.95 | Buy |
| 50-day SMA: | 496.62 | Buy |
| 200-day SMA: | 377.22 | Buy |
| 8-day EMA: | 568.69 | Buy |
| 20-day EMA: | 556.87 | Buy |
| 50-day EMA: | 511.83 | Buy |
| 200-day EMA: | 403.9 | Buy |
NVIDIA Corp. Earnings Growth & NVDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.25 per share, an increase next quarter of $0.19 per share, an increase this year of $1.72 per share, and an increase next year of $1.73 per share.
Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $13.27 per share, and an increase next year of $13.90 per share.
NVIDIA Corp. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||